Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
62.4K
-
Shares change
-
-5.38K
-
Total reported value, excl. options
-
$541K
-
Value change
-
-$46.6K
-
Number of sells
-
-1
-
Price
-
$8.66
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q4 2023
1 filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q4 2023.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.4K shares
of 240M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include IGP Investments (G.P.L.P), LP (21.1M shares), True Wind Capital Management, L.P. (13.4M shares), Clal Insurance Enterprises Holdings Ltd (7.09M shares), Phoenix Holdings Ltd. (4.06M shares), Nine Ten Capital Management LLC (3.71M shares), MORGAN STANLEY (3.61M shares), CROSSLINK CAPITAL INC (3.24M shares), Greenhaven Road Investment Management, L.P. (2.86M shares), ACADIAN ASSET MANAGEMENT LLC (2.28M shares), and Voss Capital, LLC (1.84M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.